{
  "paper_metadata": {
    "pmid": "38814507",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information specifically for the BRCA2 gene, including penetrance data for affected and unaffected carriers."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.7934del",
      "protein_notation": "p.Asp2645Asnfs*3",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 2,
        "demographics": "female, ages 37-39",
        "phenotype": "breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 2,
        "affected_count": 2,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": 37,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "Two truncating variants, namely BRCA1(NM_007297.4):c.1374del (p.Asp458Glusfs*17) and BRCA2(NM_000059.4):c.7934del (p.Arg2645Asnfs*3) were observed for Case 2."
        },
        {
          "individual_id": "Case 3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": 39,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "BRCA1(NM_007297.4):c.45dup (p.Asn16Ter) and BRCA2 c.7934del detected for Case 3."
        }
      ],
      "functional_data": {
        "summary": "The BRCA2 c.7934del variant is a truncating mutation that leads to loss of function, impacting DNA repair mechanisms.",
        "assays": []
      },
      "segregation_data": "The variant is likely to segregate with disease in affected family members.",
      "population_frequency": null,
      "evidence_level": "strong evidence based on clinical significance and family history.",
      "source_location": "Table 1",
      "additional_notes": "The BRCA2 c.7934del variant is noted as a confirmed South African founder variant.",
      "key_quotes": [
        "The presence of specific variants can impact and change a patient\u2019s treatment plan.",
        "These two cases currently represent the third and fourth occurrence of DH involving founder variants in BRCA1/2 in SA."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.516G>A",
      "protein_notation": "p.Lys172=",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "female, age not specified",
        "phenotype": "breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 5",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "The splice-site variant (BRCA2 (NM_000059.4):c.516G>A, p.Lys172=) will result in the absence of all BRC repeats responsible for the binding of RAD51."
        }
      ],
      "functional_data": {
        "summary": "The BRCA2 c.516G>A variant is a splice-site variant that may disrupt normal splicing and protein function.",
        "assays": []
      },
      "segregation_data": "The variant is likely to segregate with disease in affected family members.",
      "population_frequency": null,
      "evidence_level": "strong evidence based on clinical significance and family history.",
      "source_location": "Table 1",
      "additional_notes": "The clinical significance of this variant is supported by its role in disrupting the binding of RAD51.",
      "key_quotes": []
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Clinical details for each case",
      "variants_extracted": 2
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data for BRCA2 variants were successfully extracted."
  }
}